Brasília – The Orion project is an unprecedented public health initiative in Brazil that will build a cutting-edge laboratory complex for advanced research on infectious agents in Campinas, São Paulo. With a public investment of approximately R$1.6 billion, the facility will include the first Biosafety Level 4 (NB4) laboratory in Latin America connected to the Sirius particle accelerator, enabling high-precision studies of high-risk pathogens and accelerating the development of diagnostics, vaccines, and treatments.
Designed to boost national scientific capacity and health system resilience, the Orion complex will support advanced pathogen imaging and analysis, contribute to epidemiological surveillance strategies, and serve as a platform for pre-clinical research that can underpin public health policy and industrial innovation in Brazil. The project’s integration with Sirius and its state-of-the-art infrastructure aims to position the country among global leaders in infectious disease research and emergency preparedness.
Source: Futuro da Saúde
Need to understand Brazil’s market and political landscape?
Contact Pietro Rubin — pharmabrnews@gmail.com




Leave a Reply